After working to make its continuous glucose monitoring systems compatible with the major players in the diabetes device industry, Dexcom is opening its doors much wider. With an FDA blessing for ...

We’re witnessing massive demographic and market shifts that will accelerate the race to value-based healthcare. Case in point: The Medicare Payment Advisory Commission (MedPAC) predicts that Medicare ...

Last week the digital health world was taken by storm when news broke that virtual health giant Teladoc was set to acquire chronic care management platform Livongo in a whopping $18.5 billion deal.

Teladoc is likely to report a large charge in the first quarter of 2022, according to a 10-K filing. The charge would show that Livongo, a chronic-care company that Teladoc acquired, is losing value.

It's been one year since Teladoc's megamerger with the chronic-care company Livongo. The goal is to build one app that covers primary care, chronic care, and other services. Teladoc has faced internal ...